Which of the following is an SGLT 2 inhibitor approved for treatment of type 2 diabetes Mellitus
Canagliflozin, empagliflozin, dapagliflozin, remogliflozin are sglt 2 inhibitors approved for treatment of type 2 diabetes Ref Harrison 20th edi page no 2866, table 397-5
Dulaglutide
Pramilintide
Canagliflozin
Nateglinide
Endocrinology